Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-21-005397
Filing Date
2021-02-09
Accepted
2021-02-09 11:26:10
Documents
1
Period of Report
2021-02-09

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 3292
  Complete submission text file 0000899243-21-005397.txt   4760
Mailing Address C/O KEZAR LIFE SCIENCES, INC. 4000 SHORELINE COURT, SUITE 300 SOUTH SAN FRANCISCO CA 94080
Business Address
Henig Noreen (Reporting) CIK: 0001810995 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-40035 | Film No.: 21604671

Mailing Address 30 ROCKEFELLER PLAZA NEW YORK NY 10112
Business Address 30 ROCKEFELLER PLAZA NEW YORK NY 10112 212-623-6000
Lazard Growth Acquisition Corp. I (Issuer) CIK: 0001836337 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
SIC: 6770 Blank Checks